Skip to content

Investors

Grow with Eve.

Eve & Co is a Canadian company focused on the emerging female-focused cannabis market. Our common shares are publicly traded on the TSX Venture Exchange under the name “EVE.”

Eve & Co Incorporated, through its wholly owned subsidiary Natural MedCo Ltd., is a licensed producer and seller of dried cannabis and cannabis plants under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

As the cannabis industry matures, Eve & Co will continue to provide educational information and online support for its customers and first-time buyers.

For more information, contact investor relations at 1-855-NAT-MEDS or invest@naturalmedco.ca.

**Please note that this telephone line is for investor relations inquiries only. We respectfully ask that all sales presentations/information be directed to info@naturalmedco.ca. Thank you.

Executive Team

Melinda Rombouts - President, CEO

Prior to founding NMC, Ms. Rombouts was the president, manager and owner of numerous large scale businesses producing agricultural food and pharmaceutical related products. Through this experience she has gained extensive plant knowledge crucial to the growth of a healthy plant and high quality product.

Ms. Rombouts has grown hundreds of varieties of plants and has experience with quality assurance and GPP program development, implementation and improvement with strict adherence to the regulations governing the pharmaceutical industry.

Landon Roedding - CFO

Mr. Roedding brings over 15 years of experience in accounting, financing, and business development within the public markets and has a demonstrated ability to manage financial and operational challenges while managing a dynamic and growing business.

Previously, Mr. Roedding was Controller at Blue Goose Capital Corp., where he led the financial planning, reporting, restructuring and human resource functions. Prior to his role at Blue Goose Capital, Mr. Roedding was Director, Financial Reporting at Kinross Gold, focusing on financial and management reporting as well as internal controls, and Senior Manager of Financial Reporting at Sherritt International Inc., where he led the financial reporting function, upgraded reporting systems and supported M&A activities. Mr Roedding also spent 8 years at PricewaterhouseCoopers LLP, gaining  significant experience in public company reporting, technical IFRS accounting and supporting M&A activity.

Mr. Roedding is a Canadian Chartered Professional Accountant and holds an Honours Economics and Accounting degree from Wilfrid Laurier University. Mr. Roedding also serves on the Board of Directors of Project C.A.N.O.E., a not-for-profit charity focused on serving youth facing systemic or mental health barriers.

Mehraneh Ebrahimi - Director

Dr. Ebrahimi is the head of academic research of her family’s investment business, which holds various interests in agricultural, real estate and private equities. Prior to that, she taught at Western University in London, Ontario, where she received her PhD in World Literature.

Speaking four languages and conducting research on the role of the disenfranchised, women, and minorities in world affairs have helped Dr. Ebrahimi understand the unique international cultural kaleidoscope of Canada.

She is the recipient of several teaching awards and scholarships and the author of a forthcoming book entitled Women, Art and Literature in Diaspora. Her diverse experiences both academic and managerial shape her understanding of business and social life, especially women and immigrants.

Clark Moeller - Director

Mr. Moeller lives in Wichita, Kansas and is the head of EQ Development, a company focussed on private equity investments. With a background in lodging, commercial and residential real estate development, Mr. Moeller also has extensive experience in business operations across a wide variety of segments.

Mr. Moeller has broad experience in the cannabis industry with investments in Canada and the Colorado market.

Mr. Moeller graduated with honors and received his B.A. in United States History from the University of Kansas.

Ravi Sood - Director

Mr. Sood is the managing director of Signal 8 Limited. Mr. Sood has been a founder of and the principal investor in several businesses in emerging markets and currently serves as Executive Chairman and Director of Galane Gold Ltd. (TSXV:GG) and Blockchain Power Trust (TSXV:BPWR) and as a director of Feronia Inc. (TSXV:FRN), and ICC Labs Inc. (TSXV:ICC).

He was the founder and Chief Executive Officer of Navina Asset Management Inc., a global asset management firm headquartered in Toronto, Canada. Mr. Sood led the investment activities of Navina and its predecessor company, Lawrence Asset Management Inc., from its founding in 2001 until he sold the firm in 2010.

Shari Mogk-Edwards - Director

Shari Mogk-Edwards is an expert in the beverage alcohol industry. Her career spans 36 years with the world’s largest single buyer of beverage alcohol in the world – the Liquor Control Board of Ontario. As the Vice President, Products, Sales and Merchandising, Shari led a high performance team of 100 category and inventory specialists, directed sales of over $5.5B, tasted thousands of products and collaborated with the most celebrated producers around the world. She developed and led VINTAGES, the fine wine department at LCBO to annual sales from $23M to over $500M, through innovative programs. As the face of LCBO, Shari managed her Shari’s Picks program, traveled the world and regularly represented LCBO at trade, television and radio events, and made countless appearances as was a key note speaker. During her extensive career at LCBO, Shari lead the way for professionals in the beverage alcohol industry. She was the proud recipient of the first trade partnership award, became an international wine judge, and is a dedicated advocate and supporter of leaders.

In her new company, Shari is focused on breaking down barriers and developing businesses. She shares her knowledge and experiences through her unique, personal approach.

Investor News

Eve & Co Incorporated Engages Vertex Strategies Inc.

July 10, 2018

Eve & Co Incorporated Engages Vertex Strategies Inc. TORONTO, July 10, 2018 -- Eve & Co Incorporated (the “Company” or “EVE”) (TSXV:EVE) is pleased to ...

Learn More

Eve & Co Incorporated Begins Trading on the TSX Venture Exchange

July 4, 2018

Eve & Co Incorporated (the “Company” or “EVE”) (TSXV:EVE) is pleased to announce that at the opening of the market today, EVE’s common shares will ...

Learn More

Eve & Co Incorporated Announces Closing of Qualifying Transaction

June 28, 2018

TORONTO, June 28, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (formerly Carlaw Capital V Corp.) (the “Company”) or “Eve & Co”) (NEX:CVC.H) is pleased ...

Learn More

Natural MedCo Receives Sales License for Medicinal Cannabis and Announces New “Eve” Brand

June 25, 2018

TORONTO, June 25, 2018 (GLOBE NEWSWIRE) -- Carlaw Capital V Corp. (“Carlaw”) (NEX:CVC.H) is pleased to announce that 1600978 Ontario Inc. (which operates as Natural ...

Learn More

Natural MedCo and Carlaw Capital V Corp. Announce Closing of $20.8 Million Financing and SEDAR Filing of Filing Statement

June 18, 2018

TORONTO, June 18, 2018 (GLOBE NEWSWIRE) -- 1600978 Ontario Inc. (which operates as Natural MedCo) (“NMC”) and Carlaw Capital V Corp. (the “Corporation”) (NEX:CVC.H) are ...

Learn More

Natural MedCo and Carlaw Capital V Corp. Provide Update on Qualifying Transaction

June 14, 2018

NMC and Carlaw enter into an amalgamation agreement NMC announces proposed terms of equity private placements of approximately $10,800,000 and convertible debenture private placement of ...

Learn More

Carlaw Capital V Corp. Announces Reverse Take-Over by Natural Med Company

December 18, 2017

December 18, 2017 07:00 ET Carlaw Capital V Corp. Announces Reverse Take-Over by Natural Med Company TORONTO, ONTARIO--(Marketwired - Dec. 18, 2017) - Carlaw Capital V ...

Learn More